NEO's logo.
Ticker Symbol: NEO

Neogenomics Inc.

$40.97 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001077183

Company Profile

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.

Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
Standard Industrial Classification Code (SIC code): 8734
Address: N/A
CEO: N/A
Tags:
  • Health Services
  • Medical/Nursing Services
  • Professional, Scientific, and Technical Services
  • Testing Laboratories

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $11.66
Change: -$0.23 ( -1.98%)
Days Range: $11.51 - $11.91
Beta: 1.87
52wk. High: $20.54
52wk. Low: $6.00
Ytd. Change 26.81%
50 Day Moving Average: $12.94
200 Day Moving Average: $15.34
Shares Outstanding: 127551742

Valuation

Market Cap: 148.8B
PE Ratio: -12.71
EPS (TTM): -0.9181

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A